EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TRY 1,362.95 million compared to TRY 373.65 million a year ago. Net income was TRY 192.27 million compared to TRY 190.63 million a year ago.
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
Equities
ECILC
TRAECILC91E0
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.3 TRY | +2.09% | +3.89% | +16.70% |
1st Jan change | Capi. | |
---|---|---|
+16.70% | 1.08B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ECILC Stock
- News EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
- EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023